ChenMed CEO Dr. Christopher Chen revealed that his company no longer recommends GLP-1s for seniors with obesity, citing concerning data about muscle loss and excess hospitalizations.
Strategist | strategy-catalyst
ChenMed no longer encourages members to take GLP-1s

Relevant Roles:
Chief Strategy Officers